Archive for Март, 2007
Diet Drug Acomplia (Rimonabant) Still Seen as a Winner by Sanofi
Sanofi-Aventis said on April 3rd it still has high hopes for diet drug rimonabant (Acomplia / Zimulti), even though it was rejected by a U.S. FDA advisory panel last year and recent clinical trial news has been less than wildly encouraging.
Marc Cluzel, Sanofi’s head of research, said [...]
Zydus Cadila, an Indian manufacturer of generic drugs headed by one of the country’s richest men, said on May 17th it has launched a version of the new Sanofi-Aventis diet drug Acomplia (rimonabant) under the name Slimona .
“ Slimona (Rimonabant) is a selective CB1 Endocannabinoid (EC) [...]
Rimonabant (Acomplia / Zimulti) May Help Block Development of Alcoholic Fatty Liver
Diet drug rimonabant ( Acomplia / Zimulti), which has been approved for use in Europe and a number of other countries but not the United States, may be useful in blocking the development of alcoholic fatty liver, according to U.S. researchers.
Reporting in the March issue [...]
The Role of Adipokines
The link between obesity and its sequelae, diabetes and cardiovascular disease, has been a topic of frequent discussion and debate. Adipokines (adipose cell hormones rimonabant.) may provide a superior understanding of the link between these diseases. In the past, it was assumed that fat was simply a storage depot for energy measurement [...]
Cat Scans Confirm Rimonabant (Acomplia) Reduces Dangerous Abdominal Obesity
Cat (CT) scans of obese patients treated with Acomplia (rimonabant) have confirmed for the first time that the diet drug significantly reduces the dangerous type of abdominal obesity that often leads to type 2 diabetes, according to researchers.
In a late-breaking report presented at the annual meeting of [...]
Q .Do I need to be home to sign for it?
Yes, Royal Mail require a signature on delivery as confirmation of receipt. You can arrange for the item to be delivered to perhaps a work address for convenience.
